Browse diseases

…ction may be indicated to achieve greater therapeutic benefit B.Obesity is a heterogeneous disease with varying effects on health, nece…

…erapies, particularly statins, are central to the prevention of atherosclerotic cardiovascular disease. However, their effectiveness is often compromised by statin-as…

…betes, hypertension, and CKD, all of which are well-established ASCVD risk factors. In fact, patients with multiple chronic condition…

…verse cardiometabolic and inflammatory profile in patients with atherosclerotic cardiovascular disease, and it functionally amplifies cytokine-responsive endothelial …

…esity and overweight. Among adults with a non-Asian background, obesity should be diagnosed if waist circumference is ≥88 cm in women o…

… in SAFE score corresponded to a 0.05-point increase in 10-year ASCVD risk, B=0.05, SE=0.005, p<0.001 (figure 1D). The findings sugge…

… by which colchicine confers clinical benefits in patients with atherosclerotic cardiovascular disease, focusing on its effects on cholesterol efflux.Methods This stu…

…lerance with ASCVD (Atherosclerotic cardiovascular disease) and residual hypertriglyceridaemia—demonstrated the tool’s ability to identify differential trial …

…Type 2 diabetes is a pathological condition characterised by impaired glucose m…

…and socioeconomic deprivation.Methods Patients with established ASCVD and residual elevated lipid levels were identified using the In…

…c acid as part of combination therapy for primary prevention of ASCVD. Baseline characteristics included a mean age of 69.2 years (SD…

…HIS) are a cornerstone of secondary prevention in patients with coronary artery disease (CAD), yet real-world implementation of guideline-directed lipid mana…